News
Bruker and Purity-IQ sign partnership agreement to transform the cannabis regulatory landscape
Bruker and Purity-IQ have joined forces to create a powerful new testing system for medical cannabis in Canada. The Purity-IQ Cannabis Fingerprint™ combines Bruker’s expertise in nuclear magnetic resonance (NMR) based screening technology with Purity-IQ’s genomics capabilities to offer...
News
Novavax to Supply 76M Doses of COVID-19 Vax to Canada
Novavax, Inc. has reached an agreement in principle with the Government of Canada to supply up to 76 million doses of NVX-CoV2373, Novavax’ COVID-19 vaccine.
Novavax and Canada expect to finalize an advance purchase agreement under which Novavax will supply...
News
FDA Clears SPI’s Ebselen for Phase II COVID-19 Trials
Sound Pharmaceuticals, Inc. (SPI) received clearance from the FDA to begin two Phase 2 studies of ebselen (SPI-1005) in COVID-19 patients. SPI-1005 is a novel anti-inflammatory drug which was recently shown to inhibit nCoV2 activity and viral replication. The...
News
Alcami Providing Commercial Manufacturing for Trevena’s Recently FDA Approved OLINVYK
Alcami, a US-based contract development and manufacturing organization (CDMO), announced that it is providing commercial manufacturing services for Trevena’s newly approved OLINVYK. OLINVYK (oliceridine) injection is an opioid approved in adults for the management of acute pain severe enough...
News
iBio Signs License Agreement with Planet Biotechnology for COVID-19 Therapeutic
iBio Inc., a biotechnology innovator and biologics contract manufacturing organization, has entered into an exclusive worldwide license agreement with Planet Biotechnology Inc. for the development of Planet’s COVID-19 therapeutic candidate, ACE2-Fc.
ACE2-Fc is a recombinant protein comprised of human angiotensin...
News
CluePoints Joins Forces with Global Growth Investor Summit Partners to Expand Market Leadership Position in Risk-Based Quality Management
CluePoints S.A., a provider of Risk-Based Study Execution (RBx) and Data Quality Oversight software for clinical trials, announced a minority investment from Summit Partners, a global growth equity investor with $21 billion in assets under management. Summit will support...
News
CDMO Ology Bioservices Wins $106M Army Contract for COVID-19 Vaccine Manufacturing Support
Ology Bioservices, a biologics contract development and manufacturing organization (CDMO), has been awarded a contract by the U.S. Army Contracting Command, located in Aberdeen Proving Ground, MD. The contract ceiling value is $106.3 million, of which $53.1 million was...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read
